Attached files

file filename
EX-23.1 - CONSENT OF RBSM LLP INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ENDRA Life Sciences Inc.end_ex231.htm
EX-3.1 - THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT AS CURRENTLY IN EFFECT - ENDRA Life Sciences Inc.end_ex31.htm
EX-10.20 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1020.htm
EX-10.19 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1019.htm
EX-10.18 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1018.htm
EX-10.17 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1017.htm
EX-10.16 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1016.htm
EX-10.15 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1015.htm
EX-10.14 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1014.htm
EX-10.13 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1013.htm
EX-10.12 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1012.htm
EX-10.11 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1011.htm
EX-10.10 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex1010.htm
EX-10.9 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex109.htm
EX-10.8 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex108.htm
EX-10.7 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex107.htm
EX-10.3 - FORM OF INCENTIVE STOCK OPTION AGREEMENT UNDER SECOND AMENDED AND RESTATED 2013 STOCK INCENTIVE PLAN - ENDRA Life Sciences Inc.end_ex103.htm
EX-10.2 - FORM OF NON QUALIFIED STOCK OPTION AWARD UNDER SECOND AMENDED AND RESTATED 2013 STOCK INCENTIVE PLAN - ENDRA Life Sciences Inc.end_ex102.htm
EX-10.1 - ENDRA INC. SECOND AMENDED AND RESTATED 2013 STOCK INCENTIVE PLAN - ENDRA Life Sciences Inc.end_ex101.htm
EX-4.9 - INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES - ENDRA Life Sciences Inc.end_ex49.htm
EX-4.8 - FORM OF PROMISSORY NOTE ISSUED BY THE REGISTRANT TO CERTAIN MEMBERS OF THE BOARD OF DIRECTORS - ENDRA Life Sciences Inc.end_ex48.htm
EX-4.7 - FORM OF CONVERTIBLE PROMISSORY NOTE - ENDRA Life Sciences Inc.end_ex47.htm
EX-4.6 - FORM OF SENIOR PROMISSORY NOTE ISSUED PURSUANT TO SECURITIES PURCHASE AGREEMENT DATED JULY 10 2013 - ENDRA Life Sciences Inc.end_ex46.htm
EX-4.5 - FORM OF WARRANT TO PURCHASE COMMON STOCK ISSUED PURSUANT TO 2015 WARRANT EXERCISE PROGRAM - ENDRA Life Sciences Inc.end_ex45.htm
EX-4.4 - FORM OF WARRANT TO PURCHASE COMMON STOCK ISSUED PURSUANT TO 2013 2014 BRIDGE FINANCING - ENDRA Life Sciences Inc.end_ex44.htm
EX-4.1 - SPECIMEN CERTIFICATE REPRESENTING SHARES OF COMMON STOCK OF THE REGISTRANT - ENDRA Life Sciences Inc.end_ex41.htm
EX-3.2 - BYLAWS OF THE REGISTRANT AS CURRENTLY IN EFFECT - ENDRA Life Sciences Inc.end_ex32.htm
S-1 - REGISTRATION STATEMENT - ENDRA Life Sciences Inc.end_drs.htm
 
 Exhibit 3.5
 
STATE OF DELAWARE
CERTIFICATE OF AMENDMENT
OF CERTIFICATE OF INCORPORATION
 
 
The corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify:
 
FIRST: That by resolution of the Board of Directors of ENDRA Inc. (the “Board of Directors”) setting forth a proposed amendment of the Third Amended and Restated Certificate of Incorporation of said corporation, the Board of Directors declared said amendment to be advisable and authorized, approved and adopted said amendment. The resolution setting forth the proposed amendment is as follows:
 
NOW, THEREFORE, BE IT RESOLVED, that the resolution FIRST set forth in the fourth paragraph of the Third Amended and Restated Certificate of Incorporation be deleted in its entirety and the following new resolution be substituted in lieu thereof:
 
FIRST: “The name of the corporation is: ENDRA Life Sciences Inc. (the “Corporation”).”
 
SECOND: That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
 
In Witness Whereof, said corporation has caused this certificate to be signed this ___ day of November 2016.
 
 
 
ENDRA Inc.
 
 
 
 
 
 
By:  
/s/ 
 
 
 
Francois Michelon, Chief Executive Officer